Bio-Rad Laboratories Class B
BIO.B
7 hedge funds and large institutions have $9.24M invested in Bio-Rad Laboratories Class B in 2020 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
18% more capital invested
Capital invested by funds: $7.84M → $9.24M (+$1.4M)
0.01% more ownership
Funds ownership: 0.34% → 0.35% (+0.01%)
0% more funds holding
Funds holding: 7 → 7 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GAM
Gemmer Asset Management
Walnut Creek,
California
|
+$153K |
| 2 |
Renaissance Technologies
New York
|
+$51.2K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$48.6K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$25.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$5.12K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CL
1
CSS LLC
Chicago,
Illinois
| $7M | – | – | – |
|
|
2
Renaissance Technologies
New York
| $1.52M | +$51.2K | +100 | +3% |
|
|
3
Morgan Stanley
New York
| $353K | -$5.12K | -10 | -1% |
|
|
4
UBS Group
Zurich,
Switzerland
| $154K | +$48.6K | +95 | +46% |
|
|
GAM
5
Gemmer Asset Management
Walnut Creek,
California
| $152K | +$153K | +299 | New |
|
6
Wells Fargo
San Francisco,
California
| $29K | – | – | – |
|
|
7
Osaic Holdings
Scottsdale,
Arizona
| $26K | +$25.6K | +50 | +5,000% |
|
|
8
Bank of America
Charlotte,
North Carolina
| – | -$2K | -5 | Closed |
|
BIO.B Hedge Fund Activity: Q3 2020 in Review
7 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q3 2020, worth a combined $9.24M — up 18% from $7.84M a quarter earlier.
Fund positioning in BIO.B was balanced in Q3 2020: 1 fund opened new positions, 1 closed out, 3 added to existing stakes and 1 trimmed.
The largest buyer was Gemmer Asset Management, opening a new position worth an estimated $153K. The largest seller was Morgan Stanley, cutting an estimated $5.12K.
- 7 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q3 2020, unchanged from Q2 2020.
- Funds reported $9.24M of Bio-Rad Laboratories Class B stock for Q3 2020, up 18% quarter-over-quarter.
- 1 fund opened new Bio-Rad Laboratories Class B positions in Q3 2020 and 1 closed out, a net change of 0 holders.
- The largest Bio-Rad Laboratories Class B buyer in Q3 2020 was Gemmer Asset Management, an estimated $153K added.
- The largest Bio-Rad Laboratories Class B seller in Q3 2020 was Morgan Stanley, an estimated $5.12K sold.
Based on aggregated 13F filings for Q3 2020.